Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab for airway inflammation in chronic obstructive pulmonary disease
CTR20255161Phase 4Active
- Sponsor
- Sanofi
- Start
- Oct 2025
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of dupilumab in chronic obstructive pulmonary disease (COPD), sponsored by Sanofi. Started Oct 2025; status: active.
02
Drugs
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20255161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20255161.